Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Makishima

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Experimental Hematology|May 1, 1996
Reversible differentiation of human monoblastic leukemia U937 cells by ML-9, an inhibitor of myosin light chain kinaseY Yamamoto-Yamaguchi, M Makishima, Y Kanatani, et al.
Leukemia Research|July 29, 1998
Induction of differentiation of myelogenous leukemia cells by humulone, a bitter in the hopY Honma, H Tobe, M Makishima, et al.
The Journal of Biological Chemistry|June 2, 2001
Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptorM Ananthanarayanan, N Balasubramanian, M Makishima, et al.
Blood|June 17, 1998
Induction of differentiation in acute promyelocytic leukemia cells by 9-cis retinoic acid alpha-tocopherol ester (9-cis tretinoin tocoferil)M Makishima, K Umesono, K Shudo, et al.
FEBS Letters|August 5, 1991
Induction of differentiation of human leukemia cells by inhibitors of myosin light chain kinaseM Makishima, Y Honma, M Hozumi, et al.
The Journal of Biological Chemistry|August 25, 1992
Biological activity of a proteoglycan form of macrophage colony-stimulating factor and its binding to type V collagenS Suzu, T Ohtsuki, M Makishima, et al.
Experimental Hematology|July 1, 1993
Differentiation of human myeloblastic leukemia ML-1 cells into macrophages by staurosporine, an inhibitor of protein kinase activitiesM Makishima, Y Honma, M Hozumi, et al.
Diabetes & Metabolism|September 19, 2017
Vitamin D receptor-targeted treatment to prevent pathological dedifferentiation of pancreatic β cells under hyperglycaemic stressA Neelankal John, Z Iqbal, S Colley, et al.
Leukemia Research|January 1, 1991
Effects of inhibitors of protein tyrosine kinase activity and/or phosphatidylinositol turnover on differentiation of some human myelomonocytic leukemia cellsM Makishima, Y Honma, M Hozumi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 1, 1990
[Myelofibrosis associated with immunological abnormalities]M Makishima, K Yamamoto, K Motoyoshi, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Experimental Hematology|May 1, 1996
Reversible differentiation of human monoblastic leukemia U937 cells by ML-9, an inhibitor of myosin light chain kinaseY Yamamoto-Yamaguchi, M Makishima, Y Kanatani, et al.
Leukemia Research|July 29, 1998
Induction of differentiation of myelogenous leukemia cells by humulone, a bitter in the hopY Honma, H Tobe, M Makishima, et al.
The Journal of Biological Chemistry|June 2, 2001
Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptorM Ananthanarayanan, N Balasubramanian, M Makishima, et al.
Blood|June 17, 1998
Induction of differentiation in acute promyelocytic leukemia cells by 9-cis retinoic acid alpha-tocopherol ester (9-cis tretinoin tocoferil)M Makishima, K Umesono, K Shudo, et al.
FEBS Letters|August 5, 1991
Induction of differentiation of human leukemia cells by inhibitors of myosin light chain kinaseM Makishima, Y Honma, M Hozumi, et al.
The Journal of Biological Chemistry|August 25, 1992
Biological activity of a proteoglycan form of macrophage colony-stimulating factor and its binding to type V collagenS Suzu, T Ohtsuki, M Makishima, et al.
Experimental Hematology|July 1, 1993
Differentiation of human myeloblastic leukemia ML-1 cells into macrophages by staurosporine, an inhibitor of protein kinase activitiesM Makishima, Y Honma, M Hozumi, et al.
Diabetes & Metabolism|September 19, 2017
Vitamin D receptor-targeted treatment to prevent pathological dedifferentiation of pancreatic β cells under hyperglycaemic stressA Neelankal John, Z Iqbal, S Colley, et al.
Leukemia Research|January 1, 1991
Effects of inhibitors of protein tyrosine kinase activity and/or phosphatidylinositol turnover on differentiation of some human myelomonocytic leukemia cellsM Makishima, Y Honma, M Hozumi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 1, 1990
[Myelofibrosis associated with immunological abnormalities]M Makishima, K Yamamoto, K Motoyoshi, et al.
Pageof 3